GOP lawmakers eye restrictions on Chinese trial data; Inside Moderna’s unlikely comeback; Italy’s $10 billion pharma family ...

Experts say there’s a myriad of factors behind the recent decrease in drug prices, and not all savings will be passed onto ...

A federal law, passed in 2024, bans imports of Russian uranium by 2028, increasing pressure to develop domestic fuel supplies ...

The Food and Drug Administration granted accelerated approval to Zenbexus, or iberdomide, in combination with daratumumab and ...

By one estimate, up to 86% of clinical trials don’t meet their recruitment targets during the trial time frame.

Lucid Group announced that Eric Muller has joined the agency as CEO on Wednesday morning. The U.K.-based parent company of ...

Moderna and Merck’s personalized mRNA cancer vaccine just cleared a huge hurdle. In the first positive Phase 3 trial for an ...

Trump’s “America First” proposal for drug reviews; Childhood vaccination coverage sits well below critical threshold; Cialis ...

Azara Healthcare appointed Ashley Basile as chief strategy officer and Josh Taylor as chief revenue officer. J.P. Morgan Life ...

Vertex Pharmaceuticals’ Casgevy, known generically as exagamglogene autotemcel, is the first CRISPR/Cas9 gene-editing therapy ...

AbbVie’s Skyrizi maintained its advertising momentum across linear and streaming TV, while BlueChew generated nearly 400 ...

Citing ProPublica’s reporting, eight senators wrote a letter to Secretary of State Marco Rubio questioning the administration ...